Understanding Heart Disease in Patients with Advanced Heart Failure

This study aims to learn more about advanced heart disease by collecting tissue and blood samples from patients with congestive heart failure (when the heart can't pump enough blood). You might be able to join if you are over 18 and have heart failure, and are having either an LVAD (Left Ventricular Assist Device, a mechanical pump that helps the heart) implanted or a heart transplant. Older children (13-18 years old) with heart failure who are large enough for an LVAD may also participate. Researchers will look at changes in how well your heart muscle works (myocardial function) at the beginning of the study and again after 3 months. This study is a registry, meaning it collects and stores information, and does not involve new treatments or procedures.

Study design
This is an observational registry study, meaning it collects data without testing new treatments. It plans to enroll 300 participants.
What's involved
Blood samples will be taken during procedures or when other lab work is done. Tissue samples will be collected during LVAD implantation, using only tissue that is already being removed.
Compensation
Not stated in the trial record.
Follow-up
Your heart function will be measured at the beginning of the study and again after 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT01099982

Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease

Recruiting
Not specifiedAges 13+Observational
University of Utah
~300 participants
Updated 2026-08-13 on ClinicalTrials.gov

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in myocardial function
Measured over baseline and 3 months
Congestive Heart Failure

NCT01099982

Where you'd take part

This study runs at 3 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Intermountain Medical Center

    Murray, Utahstudy coordinator listed

    Recruiting

  • University of Utah Health Sciences Center

    Salt Lake City, Utahstudy coordinator listed

    Recruiting

  • VA Salt Lake City Health Care System

    Salt Lake City, Utahstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Stavros Drakos, M.D., Ph.D. · PRINCIPAL_INVESTIGATOR · University of Utah Health Sciences Center & VA Salt Lake City Health Care System

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

\>18 years of age diagnosed with heart failure undergoing either LVAD implantation or heart transplantation
13 to 18 years of age, specifically, older children with heart failure whose body mass index is large enough to accommodate and LVAD

Exclusion

Neither patient nor patient representative understands spoken English
Neither patient nor patient's personal representative is willing to give written consent for participation.
  • Change in myocardial functionbaseline and 3 months

    Myocardial function, measured by left ventricular ejection fraction, will be assessed pre-LVAD implant (baseline) and compared with myocardial function assessed at 3 months post-LVAD implant